Evidence map›Paper›PMID 37312199›Full record

ArticleJournal of cardiothoracic surgery2023

Combination of CEACAM5, EpCAM and CK19 gene expressions in mediastinal lymph node micrometastasis is a prognostic factor for non-small cell lung cancer.

Hande Süer, Suat Erus, Ekin E Cesur, Ömer Yavuz, Orhan Ağcaoğlu, Pınar Bulutay, Tamer T Önder, Serhan Tanju, Şükrü Dilege

Open access · goldAbstract read
In one paragraph

Article in Journal of cardiothoracic surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Unveiling molecular incomplete response (mIR)Cancer biology & medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Hande SüerGraduate School of Health Sciences, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey. hande.suer@acibadem.edu.tr.ORCID http://orcid.org/0000-0003-4379-0332
Suat ErusThoracic Surgery Department, Koç University School of Medicine, Istanbul, Turkey.
Ekin E CesurThoracic Surgery Department, Vehbi Koç Foundation American Hospital, Istanbul, Turkey.
Ömer YavuzThoracic Surgery Department, Koç University School of Medicine, Istanbul, Turkey.
Orhan AğcaoğluGeneral Surgery Department, Koç University School of Medicine, Istanbul, Turkey.
Pınar BulutayPathology Department, Koç University School of Medicine, Istanbul, Turkey.
Tamer T ÖnderKoç University School of Medicine, Istanbul, Turkey.
Serhan TanjuThoracic Surgery Department, Koç University School of Medicine, Istanbul, Turkey.
Şükrü DilegeThoracic Surgery Department, Koç University School of Medicine, Istanbul, Turkey.
Koç University · TRAcıbadem University · TRAmerikan Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLung cancer is known as the most common and highly metastatic form of cancer worldwide. Tumour node metastasis (TNM) staging is the gold standard classification system for the decision-making process for appropriate treatment. Particularly N status has the most important prognostic value in the absence of distant metastasis. Traditional diagnostic methods are capable of detecting metastasis; however, they may fail to detect micrometastasis, which plays a role in disease recurrence and patients' long-term survival. Occult micrometastasis can change the tumour's TNM staging and, consequently, the patient's treatment regimen.

methodsThe median number of three lymph node tissues were collected from 30 patients who underwent surgery for non-small cell lung cancer. Lymph node tissues were collected from different lymph node stations according to the location of the patient's tumour. CK19, EpCAM and CEACAM5 gene expressions were analysed in tissues using quantitative real-time polymerase chain reaction to detect micrometastasis in distant lymph nodes.

resultsTriple positivity was seen in 26 out of 30 patients which 19 patients were upstaged from N0 to N2. While survival was not significantly affected between upstaged and non-upstaged patients, patients upstaged with multiple-station N2 had a significantly higher recurrence and lower survival compared to single-station N2.

conclusionA combination of CK19, EpCAM and CEACAM5 gene expressions in lymph nodes can be used to identify micrometastasis which postoperatively may be used as a tool to predict patients' recurrence and survival.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsCarcinoembryonic AntigenEpithelial Cell Adhesion MoleculeGene ExpressionGPI-Linked ProteinsHumansKeratin-19Lymph NodesNeoplasm MicrometastasisPrognosisCarcinoembryonic AntigenCEACAM5 protein, humanEPCAM protein, humanEpithelial Cell Adhesion MoleculeGPI-Linked ProteinsKeratin-19KRT19 protein, humanCancerMediastinal lymph node micrometastasisMicrometastasisNSCLCSkip metastasis

Identifiers

PMID37312199
PMCPMC10262366
OpenAlexW4380538160

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.